Ningxia Zhongke Biotechnology Co., Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 168.61 million compared to CNY 606.12 million a year ago. Revenue was CNY 168.61 million compared to CNY 606.12 million a year ago.

Net loss was CNY 220.22 million compared to CNY 21.42 million a year ago. Basic loss per share from continuing operations was CNY 0.322 compared to CNY 0.031 a year ago. Diluted loss per share from continuing operations was CNY 0.322 compared to CNY 0.031 a year ago.